Galena Biopharma fka GALE

[justthefacts1]

Law Offices of Howard G. Smith Announces an Expanded Class Period in the Shareholder Lawsuit against Galena Biopharma, Inc.

BENSALEM, Pa.--(BUSINESS WIRE)--

Law Offices of Howard G. Smith announces that the class action lawsuit against Galena Biopharma, Inc. (“Galena” or the “Company”) (GALE) filed in the United States District Court for the District of Oregon has been expanded to include all purchasers of Galena common stock between May 9, 2013 and March 17, 2014, inclusive (the “Class Period”).

Galena is a biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. The Complaint alleges that throughout the Class Period defendants misrepresented and/or failed to disclose that: (1) the Company hired a promoter – The DreamTeam Group – to boost Galena’s share price; (2) the promoter posted misleading articles on Galena’s behalf without properly disclosing its paid marketing relationship; and (3) as a result, the Company’s statements were materially false and misleading at all relevant times.

If you purchased Galena shares during the Class Period, you may move the Court no later than May 5, 2014, to serve as lead plaintiff, if you meet certain legal requirements. To be a member of the Class, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at [phone], Toll Free at [phone], or by email to [e-mail], or visit our website at www.howardsmithlaw.com.